Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;90(2):216-21.
doi: 10.1016/j.diabres.2010.08.012. Epub 2010 Sep 15.

The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version

Affiliations

The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version

Harith Kh Al-Qazaz et al. Diabetes Res Clin Pract. 2010 Nov.

Abstract

Aims: To translate and examine the psychometric properties of the Malaysian version of the Morisky Medication Adherence Scale (MMAS) among patients with type 2 diabetes.

Methods: A standard "forward-backward" procedure was used to translate MMAS into Malay language. It was later validated on a convenience sample of 223 type 2 diabetes outpatients between May and September 2009. Reliability was tested for internal consistency. Validity was confirmed using convergent and known group validity.

Results: Employing the recommended scoring method, the mean±SD of MMAS scores was 6.13±1.72. Moderate internal consistency was found (Cronbach's α=0.675), the test-retest reliability value was 0.816 (p<0.001). A positive correlation between the eight- and four-item MMAS was found (r=0.792; p<0.01). A significant relationship between MMAS categories and HbA1c categories (χ(2)=20.261; p≥0.001) was found. The MMAS sensitivity and specificity, with positive and negative predictive values were 77.61%, 45.37%, 46.84% and 76.56%, respectively.

Conclusions: The findings of this validation study indicate that the Malaysian version of the MMAS is a reliable and valid measure of medication adherence which can now be used.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Similar articles

Cited by

References

    1. International Diabetes Federation. Diabetes atlas. 3. Brussels, Belgium: International Diabetes Federation; 2006.
    1. NHM III. [accessed 23.07.09];The Third National and Morbidity Survey. 2006 Available at http://www.nih.gov.my/NHMS/abstracts_17.html.
    1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–53. - PubMed
    1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7. - PubMed
    1. Rubin Richard R. Adherence to pharmacologic therapy in patients with Type 2 diabetes mellitus. Am J Med. 2005;118:27S–34S. - PubMed

Publication types